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Background: Trauma such as hip fracture initiates a neurohumoral stress response that changes the balance between
anabolism and catabolism resulting in muscle breakdown and reduced mobilisation. Various studies have
demonstrated a reduction in catabolism with pre-operative carbohydrate loading but only in an elective setting.
Methods/Design: This is a two-centre, randomised double-blinded trial in the United Kingdom. Sample size will be
30 patients (approximately 15 from each centre).
Randomisation will be web based using computer-generated concealed tables. Both participants and investigators will
be blinded to group allocation.
Participants will be >70 years of age, cognitively intact (Abbreviated Mental Score ≥7), able to give informed consent,
and admitted directly through the emergency department with fractured neck of femur requiring hemiarthroplasty.
Intervention will consist of two carbohydrate drinks (Nutricia pre-Op) given the night before, and the morning of the
surgery. The control will receive two placebo drinks of equal volume.
All participants will receive standard hospital care at the discretion of the clinical team. The primary outcome is the
difference between groups in insulin resistance calculated by a glucose tolerance test administered pre-operatively and
24 hours postoperatively. Secondary endpoints will be changes in muscle carbohydrate metabolism (biopsy), mobility
(Cumulative Ambulation Score) and subjective measures of tolerability.
Discussion: This is a small-scale pilot study, investigating the benefits and tolerability of carbohydrate loading in an
emergency setting in a frail elderly group with known high morbidity and mortality. Positive findings will provide the
basis for a larger scale study.
Trial registration: Current Controlled Trials ISRCTN91109766 (7 April 2014); NRES ref: 13/EM/0214
Trial Sponsor: University of Nottingham Ref.13036.
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Trauma induces a widespread neurohumoral stress re-
sponse. This results in changes in the balance between
anabolic (growth) and catabolic (destructive) functions
within the body. This has many effects, including in-
creased catabolism, release of pro-inflammatory cytokines
and activation of the sympatho-adrenal system.
Insulin resistance (IR) is believed to be a fundamental
component regulating the change in the balance be-
tween anabolism and catabolism [1].
Insulin resistance is a metabolic state of reduced hepatic
and peripheral (mainly muscle) responsiveness to insulin.
Chronically, around 85% of Type II diabetics and 20% of
non-diabetic individuals have biochemically defined insu-
lin resistance [2]. In the peri-operative period, insulin re-
sistance has a rapid onset [3], is predominantly of muscle
origin and persists for a considerable period (weeks) fol-
lowing surgery. It appears to be, at least in part, a response
to trauma and reduced energy intake [4].
The severity of insulin resistance is directly proportional
to the magnitude of the surgical insult. It is also related to
the development of postoperative complications [5]. Insu-
lin resistance occurs in parallel with multiple other meta-
bolic effects including decreased muscle carbohydrate
oxidation, increased muscle catabolism, negative nitrogen
balance, reduced muscle mass [6] and reduced muscle
strength [7]. It is possible that they share a common sig-
nalling pathway.
There has been considerable work investigating the ef-
fect of differing forms of anaesthesia and surgery on the
quality of this stress response. Minimally invasive surgery
reduces, but does not eliminate, the stress response, and
the beneficial effects may be dependent upon the type of
surgery [8]. Regional anaesthesia, if complete, may abolish
the adrenocortical, glycaemic and some of the inflamma-
tory responses, but it does not abolish all of the cytokine
responses to tissue trauma [9]. It has not been shown to
improve outcome following hip fracture [10].
In recent years, a whole system approach to ameliorat-
ing the response to surgery has been introduced. The
‘Enhanced Recovery after Surgery’ approach (ERAS) aims
to minimise all aspects of the surgical pathway that might
impede recovery. Individual components of the bundle are
of benefit with regard to surrogate and/or clinical out-
comes. As a whole, the bundle has been associated with
improved outcomes in a meta-analysis of randomised
studies [11]. These studies, however, have only involved
elective patients.
Carbohydrate loading
The traditional approach to pre-operative preparation of
patients involves a relatively prolonged period of pre-
operative food and water starvation. This has been done
to reduce the real, though small, risks of pulmonaryaspiration of stomach contents. More recently it has been
recognised that this approach induces the body’s starva-
tion response. This may then be exacerbated by the cata-
bolic effects of surgery. Several groups have demonstrated
the beneficial effects of mitigating this by providing pa-
tients with carbohydrate drinks the evening before and
morning of surgery.
Some of the beneficial effects seen in humans include
reductions in insulin resistance and hyperglycaemia [12],
postoperative nausea and vomiting [13], pre-operative dis-
comfort [14] and preservation of muscle mass [15].
There is reasonable evidence for the safety of carbohy-
drate drinks [16]. Studies in volunteers [17], cardiac and
general surgical [18] patients have not demonstrated in-
creased gastric volumes when such drinks are given up to
two hours before surgery.
Studies of oral carbohydrate loading have demon-
strated a reduction in insulin resistance of approximately
50% in elective orthopaedic, colorectal and laparoscopic
surgery [19], and the effect appears to be prolonged
[8,12,16].
It is apparent that being in the fed versus the fasted state
improves outcome following surgical stress; however, the
exact reason for this is unclear. By avoiding depletion of
liver glycogen reserves, there is a more rapid release of
glucose from the liver into blood. Animal studies suggest
that this results in a hyperosmolar state with possible ben-
efits in fluid distribution and cardiovascular performance
[19]. It may also affect immune function and reduce
muscle protein catabolism, thereby maintaining muscle
performance.
During the early phase of postoperative insulin resist-
ance, the main defect is in the process of glucose uptake
into the muscle. Specific glucose transporters (GLUT4)
are not activated in the normal way by the action of cir-
culating insulin [20].
More recent work has shown that the intracellular sig-
nalling systems that activate GLUT4, including PI-3-
kinase, are downregulated while other signalling systems,
which activate the inflammatory responses, are upregu-
lated both in muscle [21] and fat tissue [22]. Animal work
from the laboratory of one of the authors has demon-
strated that a systemic inflammatory response increases
the expression of pro-inflammatory cytokines in muscle,
resulting in impaired PI-3-kinase signalling and the activa-
tion of downstream transcription FOXO factors. This has
the effect of increasing the expression of muscle pyruvate
dehydrogenase kinase 4 and muscle atrogene mRNA and
protein. Collectively, these molecular responses impair
muscle pyruvate dehydrogenase complex activation and
carbohydrate use, as well as increasing proteasomal and
cathepsin L activity and thereby muscle protein loss [23].
Translation of these findings has revealed that the same
molecular events occur in intensive care patients [24] who
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drate loading resulted in a reduction in the peri-operative
induction of PDK4 mRNA, which inhibits oxidative
carbohydrate metabolism [25].
These alterations in molecular signalling secondary to
surgical stress are associated with a host of negative
physiological effects postoperatively such as impaired glu-
cose tolerance, decreased mitochondrial ATP production,
increased gut permeability, increased free circulating fatty
acids, decreased muscle glycogen levels and increased
levels of blood lactate [26,27].
Furthermore, it has been shown that increased muscle
PDK4 expression inhibits the activity of pyruvate de-
hydrogenase complex (PDC), which controls the rate of
muscle carbohydrate (CHO) oxidation in mitochondria.
It is theorised that impaired PI3K/Akt1/FOXO signalling
and the resultant upregulation of PDK4 are important
factors underlying the development of muscle insulin re-
sistance [28,29].
Muscle metabolism
Muscle metabolism and function is fundamental to post-
operative recovery. Previous research on muscle metab-
olism following trauma and acute illness has largely
focussed on organ-level changes in nitrogen balance and
glucose metabolism. More recently research into the
acute effects of illness on the transcriptional pathways
involved in muscle homeostasis have shown that the
changes are not a simple on/off phenomenon with some
evidence of balancing anabolic processes being switched
on shortly after the onset of sepsis. Although basal
muscle metabolism is unaffected by age, the ability to in-
corporate amino acids following food may be different
in the elderly [30] – so-called anabolic resistance.
Our study will investigate whether pre-operative CHO
feeding has the ability to counter the cytokine mediated
impairment of Akt phosphorylation caused by surgical
stress, ultimately reducing the degree of insulin resistance.
Hip fracture
Fragility hip fracture is a very significant burden to pa-
tients, carers and the health service [31]. Patients with fra-
gility hip fracture have a poor outcome in terms of
mortality and functional recovery [32,33]. They also have
a considerable hospital and rehabilitation length of stay.
Early mobility is associated with better outcome [34], and
the degree of mobility following discharge is linked to late
mortality [35]. General muscle strength (not just lower
limb strength) is associated with degree of functional re-
covery following hip fracture [36].
Careful multi-disciplinary pre-operative assessment and
optimisation for surgery has been shown to improve func-
tional outcomes and mortality. However, recent NICE
guidance does not include the requirement for nutritionalassessment. There is some evidence that nutritional
intervention as part of a comprehensive hip fracture
programme improves outcomes [37], and may reduce
postoperative complications [38]. There are however no
metabolic studies investigating pre-operative carbohy-
drate loading in this patient group.
There are few data regarding the stress response in the
very elderly (the median age of hip fracture patients is ap-
proximately 84 years). Kudoh and colleagues [39] demon-
strated differences between the very elderly and younger
patients undergoing hip fracture surgery with regard to
norepinephrine and cortisol responses, though the lack of
analgesia in this study raises questions over relevance to
modern practice. Pro-inflammatory cytokine responses
appear to be augmented in the very elderly [40]. Sun and
colleagues demonstrated a rise in plasma concentrations
of pro-inflammatory cytokines following admission with
hip fracture in the elderly, and the magnitude of this re-
sponse was predictive of 6 month and 12 month mortality
[41]. Studies of insulin resistance have had few or no pa-
tients over 80 [42,43].
Qualitatively, the hormonal response following minor
surgery appears similar in younger and in older (70 to
75 years) patients [44,45]. Previous researchers have dem-
onstrated an early and persisting loss of muscle mass fol-
lowing hip fracture [46], which may be one reason for the
decline in function and persistent insulin resistance seen
following injury. These data would suggest that if practical
strategies to reduce insulin resistance were available, there
may be possible outcome benefits for patients following
hip fracture.
Previous studies using pharmacological modulation of
muscle metabolism in this patient group have shown con-
flicting results. Studies using human growth hormone or
similar drugs have reported increased side effects in the
treatment groups [47,48].
Postoperative nutritional supplementation has had some
favourable results [49] but has suffered with poor compli-
ance. A Cochrane review of nutritional supplementation
found only weak evidence of benefit [50]. One reason for
this may be that the intervention is insufficient in patients
who are already in a catabolic state after surgery. Pre-
surgical intervention may not only provide nutrition but
also modulate the catabolic response.
There has been a relatively successful national drive to
reduce the time between admission and surgery for pa-
tients with hip fracture. According to the latest results
from the National Hip Fracture Database 2013 71.4% of
patients received their operation within 36 hours [51].
Nonetheless, this still provides a considerable period when
patients may be kept nil by mouth awaiting operation. Ac-
curate data for true starvation periods are scarce. A small
audit from a UK District General Hospital found ‘average’
starvation times after 7 am of 4 to 6 hours, which should
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most patients are now given intravenous rehydration
whilst waiting for theatre, food is less commonly given
and nausea is a common complication of the injury, pain
and the opioids given for analgesia.
There is a small amount of evidence of impaired glu-
cose homeostasis in hip fracture patients. Liu found evi-
dence of postoperative hyperglycaemia in around 70% of
patients [41]. Around 40% of patients from the recently
completed NOTTS study [53,54] are hyperglycaemic
prior to induction of anaesthesia.
However, the evidence from elective surgery may not be
directly applicable to hip fracture patients. First, by defin-
ition, these patients have already suffered one traumatic
insult (the injury) so the catabolic processes may have
already begun. Second, the carbohydrate loading studies
have generally used an 800-ml drink the night before sur-
gery and a 200-ml drink on the morning of surgery. Al-
though this is well tolerated in elective surgical patients, it
may not be so well tolerated by frail elderly patients.
Third, approximately 50% of hip fracture surgery is per-
formed under spinal anaesthesia [51]. There is some evi-
dence from elective surgery that this may diminish the
impact of carbohydrate loading, presumably due to the re-




To investigate whether pre-operative carbohydrate loading
(using Nutricia pre-op drinks) results in an improvement
in insulin resistance in patients undergoing hemiarthro-
plasty for a fragility fracture of the neck of femur.
Secondary aims
Does pre-operative carbohydrate loading in elderly hip
fracture patients have other benefits in the post-operative
period? The following will be evaluated to determine this:
1. Muscle metabolism.
2. Functional mobility (measure with the Cumulative
Ambulation Score).
3. Infectious/cardiovascular complications.
4. Length of acute hospital stay.
Study design
This is a prospective, parallel group, double-blind (par-
ticipant and investigators), randomised controlled clin-
ical trial.
Two centres will participate: Queen’s Medical Centre
campus of Nottingham University Hospitals and Pilgrim
Hospital, United Lincolnshire Hospitals, Boston.
Recruitment started in September 2014, and total re-
cruitment in expected to take 12 to 18 months.Randomisation and blinding
Randomisation (on a one-to-one basis) will be provided
by a password-protected web-based randomisation ser-
vice, with sequence not revealed until data lock. Partici-
pants will be randomised after x-ray confirmation of a
displaced intracapsular fracture of the neck of femur and
appropriate assessment and counselling from a member
of the research team.
The investigators, patient, nurses and data-collection
staff will all be blinded to treatment allocation. Drinks will
be prepared by a separate member of staff who will not be
blinded for practical reasons but who will not take part in
any aspect of the study apart from preparation of the
drinks.
The assessment of Cumulative Ambulation Score will
be made by the ward physiotherapists treating the pa-
tient. The multiprofessional team makes the decision
that a patient is medically fit for discharge when all are
satisfied that the participant has no ongoing needs for
acute hospital care. This team is blinded to participant
allocation.
Selection and withdrawal of participants
Recruitment
Participants will be identified by nurses in the Emergency
Department, who will then inform a member of the re-
search team about the presence of the patient. Once a pa-
tient has been identified, a member of the research team
will approach the patient and conduct the initial screening
and consenting of the patient. Active participation in the
study will be until the second glucose tolerance test has
been performed 24 hours after surgical fixation.
Participants will be informed that participation is vol-
untary and that they are free to withdraw at any time
without affecting their care.
Data on time to discharge and mortality are routinely
collected on all hip fracture patients at each institution,
and participation in the trial will involve consent for this
data to be used.
Patients unable to provide informed consent will be ex-
cluded from the trial. Patients for whom language will be
a barrier will also be excluded due to the small scale na-
ture of the study. Patient information will not be available
in languages other than English. In practice, non-English
speakers represent a very small number of patients in this
population group.
Inclusion criteria
Inclusion criteria include the following:
1. Primary hip fracture listed for surgical repair using
hemiarthroplasty.
2. Age over 70 years.
3. Able to give informed consent.
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Exclusion criteria include the following:
1. Pre-existing diabetes (type I or II).
2. Intercurrent infection.
3. Ongoing participation in another interventional
clinical trial.
4. Previous intolerance to carbohydrate drinks.
5. Any condition or impairment, which, in the view of
the investigator, would prohibit the patient from full
participation in the study.Informed consent
Informed consent is obtained from every participant. The
capacity for providing consent is assessed routinely by the
orthopaedic team, which decides whether the patient is
competent to provide consent for the surgical procedure.
If the orthopaedic team deems the patient unable to con-
sent to surgery, then the patient will be deemed incapable
of consenting to enter the study. A member of the re-
search team also performs an additional check of the par-
ticipant’s ability to provide consent immediately prior to
starting the study. All members of the research team are
trained at obtaining consent in accordance with guidance
for good clinical practice [55].
The trial received favourable ethical approval from the
NRES Committee East Midlands-Nottingham 1 on 15
July 2013.Study intervention
All patients enrolled into the trial will receive a baseline
glucose tolerance test a minimum of four hours after their
last oral intake. Routine practice at both study centres is
to place patients with diagnosed hip fractures nil by
mouth until an operating theatre time is identified. Once
this test is performed patients allocated to the active group
will receive 400 ml of carbohydrate drink (Nutricia Pre-
op). Patients in the control arm will receive 400 ml of diet
(sugar free) lemon drink. This will be administered by the
investigator from an opaque jug to reduce identification of
the drink. A further 400 ml of either carbohydrate drink
or of placebo will be administered by nursing staff at
06:00 hours on the morning of surgery. This is to allow a
minimum of two hours fasting pre-operatively, which is
standard policy at both sites.
Three muscle biopsies will be performed in total, taken
from the vastus lateralis: one after anaesthesia but before
surgery in the non-fractured leg, with sample two being
taken after wound closure but before wake up (for general
anaesthesia) or resolution of regional anaesthesia. The
third muscle biopsy will be taken 24 hours after the end of
surgery at approximately the same time as the second glu-
cose tolerance test. All muscle biopsies will be snap frozenin liquid nitrogen and stored at -80°C before transport to
the muscle physiology laboratory for analysis.
Standard care
Standard care will be identical in both groups. Only the
administration of the carbohydrate drink will differ be-
tween groups.
All patients are admitted to dedicated trauma wards and
cared for in accordance with UK ‘Best Practice Tariff ’
[56,57].
This includes assessment by orthogeriatricians, oper-
ation within 36 hours of admission, and assessment of
bone health and falls. All patients are cared for under a
hip fracture care pathway, which involves rapid assess-
ment and admission from the emergency department,
intravenous crystalloid infusions from the time of admis-
sion, and multiprofessional care and discharge planning.
Operations are performed in dedicated trauma theatres by
appropriately experienced surgeons and anaesthetists.
The surgical stress response per se generates insulin
resistance; therefore the protocol does not allow a de
novo diagnosis of diabetes. However, glucose tolerance
test results will be available to the clinical team to make
appropriate clinical decisions.
Concomitant medication
Analgesia will be provided in accordance with nor-
mal practice at the study centre. Non-steroidal anti-
inflammatory drugs are not routinely prescribed for this
group of patient due to their side effects. Other medica-
tions will be prescribed by the attending medical staff as
appropriate for each individual.
Concomitant treatments
Anaesthesia will be at the discretion of the attending an-
aesthetist. Other post-operative therapies such as physio-
therapy will be in accordance with routine hospital
practice at the relevant centre.
Laboratory analysis
Glucose tolerance test blood will be analysed on a bed-
side blood glucose analyser (Hemocue, Brea CA, USA).
C-peptide and insulin levels, along with all muscle biopsy
samples, will be analysed by Professor Greenhaff ’s team at
the MRC-ARUK Centre for Musculoskeletal Ageing Re-
search, University of Nottingham.
Muscle metabolism
Laboratory analysis will be performed by Professor
Greenhaff ’s team at the School of Biomedical Sciences
University of Nottingham. This will include PCR/western
blot and spectrophotometric analysis. The following pa-
rameters will be examined:
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inflammatory processes, assessed using real-time
PCR.
2. AKT protein phosphorylation-phosphorylates
FOXO, leading to decreased FOXO activity, assessed
using western blotting.
3. FOXO 1 and 3 protein phosphorylation, induces
PDK4 transcription, assessed using western blotting.
4. PDK 2 and PDK4 (pyruvate dehydrogenase
lipoamide kinase isozyme 4) mRNA and protein
expression, muscle-specific isoform known to inhibit
PDC activation, assessed using real-time PCR and
western blotting.
5. Glycogen, muscle store of carbohydrate, assessed
using spectrophotometry.
6. PDC (pyruvate dehydrogenase complex) protein
activation status, rate limiting enzyme for
mitochondrial carbohydrate oxidation, assessed
using a radioimmunoassay.
Discussion
This is a small-scale pilot study. Preoperative carbohydrate
loading has been shown to be effective in suppressing the
insulin resistance that develops in other postsurgical pop-
ulations, but its use has never been investigated in an
emergency hip fracture population.
Carbohydrate loading is a relatively cheap intervention
with little or no side effects which, if shown to be of bene-
fit, could be rolled out across the whole patient population
and included as part of an emergency hip fracture en-
hanced recovery programme. Conversely, it may be of lit-
tle benefit and resources could be directed elsewhere. The
secondary data on the metabolic effects of trauma in the
elderly will provide important insights into ageing physi-
ology that will be of increasing importance as the popula-
tion demographic changes.
It is hoped that if this study shows positive effects, it will
serve as a guide for larger studies investigating carbohy-
drate loading in emergency patients.
Trial status
NUH NHS R and I approval was gained on 24 April 2014
The trial started recruiting September 2014.
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